Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Surg Pathol ; 17(6): 432-7, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19403545

RESUMO

Rio Grande do Norte (RN) shows the highest relative incidence of papillary carcinomas in Brazil. To analyze histological features that might be associated with this incidence, the authors compared thyroid glands from 463 autopsies performed in RN with 427 surgical and autopsy glands previously studied in Sao Paulo (SP). The authors found 41 papillary thyroid microcarcinomas (PTMs) in 35 glands (8.1%), an incidence similar to the one reported in SP (7.8%). However, PTMs were predominantly nonencapsulated nonsclerosing at microscopy (44.0%), in contrast with SP where these types of lesion represented only 4 out of 32 PTMs (12.5%; P = .0046). The authors suggest that these nonencapsulated lesions with no sign of inflammation may represent an early stage that may evolve to clinical cancers, contributing to the high incidence of clinically differentiated thyroid carcinomas observed in RN.


Assuntos
Carcinoma Papilar/patologia , Inflamação/patologia , Neoplasias da Glândula Tireoide/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Autopsia , Brasil/epidemiologia , Carcinoma Papilar/complicações , Carcinoma Papilar/epidemiologia , Criança , Progressão da Doença , Feminino , Fibrose/patologia , Bócio Nodular/complicações , Bócio Nodular/epidemiologia , Bócio Nodular/patologia , Humanos , Achados Incidentais , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/complicações , Neoplasias da Glândula Tireoide/epidemiologia , Adulto Jovem
2.
Biometals ; 21(2): 171-8, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17636394

RESUMO

Tamoxifen (TX), a drug used in the treatment of breast cancer, may cause hepatic changes in some patients. The consequences of its use on the liver tissues of rats with or without diabetes mellitus (DM) have not been fully explored. The purpose of this study was to evaluate the correlation between plasma hepatic enzyme levels and the presence of iron overload in the hepatic tissue of female Wistar rats with or without streptozotocin-induced DM and using TX. Female rats were studied in control groups: C-0 (non-drug users), C-V (sorbitol vehicle only) and C-TX (using TX). DM (diabetic non-drug users) and DM-TX (diabetics using TX) were the test groups. Sixty days after induced DM, blood samples were collected for glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) alkaline phosphatase (ALP) and bilirubin measures. Hepatic fragments were processed and stained with hematoxylin and eosin, Masson's trichrome, Perls. The hepatic iron content was quantified by atomic absorption spectrometry. AST, ALT and ALP levels were significantly elevated in the DM and DM-TX groups, with unchanged bilirubin levels. Liver iron overload using Perls stain and atomic absorption spectrometry were observed exclusively in groups C-TX and DM-TX. There was positive correlation between AST, ALT and ALP levels and microscopic hepatic siderosis intensity in group DM-TX. In conclusion, TX administration is associated with liver siderosis in diabetic and non-diabetic rats. In addition, TX induced liver iron overload with unaltered hepatic function in non-diabetic rats and may be a useful tool for investigating the biological control of iron metabolism.


Assuntos
Antineoplásicos Hormonais/farmacologia , Antineoplásicos Hormonais/toxicidade , Ferro/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Tamoxifeno/farmacologia , Tamoxifeno/toxicidade , Animais , Antineoplásicos Hormonais/uso terapêutico , Glicemia/metabolismo , Neoplasias da Mama/tratamento farmacológico , Diabetes Mellitus Experimental , Feminino , Humanos , Fígado/citologia , Distribuição Aleatória , Ratos , Ratos Wistar , Tamoxifeno/uso terapêutico
3.
Contraception ; 67(5): 385-90, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12742562

RESUMO

During the last three decades, Brazilians have relied almost exclusively on two contraceptive methods, the pill and female sterilization, with sterilization use increasing over time. Until a new law was passed in 1997, sterilization was virtually illegal and not covered by either public or private health insurance. It was, however, frequently provided in public and private hospitals in conjunction with a cesarean section. The new law regulating sterilization provided for reimbursement for interval sterilizations by public health insurance, but placed restrictions on availability intended to reduce the use of cesareans. These restrictions included the prohibition of postpartum sterilizations. This paper focuses on women's sterilization intentions during pregnancy and their experiences postpartum. In a prospective study of 1612 pregnant women carried out in four Brazilian cities, there was substantial demand for postpartum sterilization in both the private and public sectors among women who wanted no more children. However, public patients were much less likely to be sterilized than private patients. Thus, the new law may not have reduced inequities in access or, paradoxically, the incentive for unnecessary cesarean sections.


Assuntos
Cesárea/estatística & dados numéricos , Necessidades e Demandas de Serviços de Saúde , Esterilização Tubária/estatística & dados numéricos , Adolescente , Adulto , Brasil , Feminino , Humanos , Período Pós-Parto , Gravidez , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...